UK MHRA responds to frequent queries on device registration
This article was originally published in RAJ Devices
The UK Medicines and Healthcare products Regulatory Agency has added a new “frequently asked questions” section to its website outlining responses to common queries from device manufacturers and sponsors regarding product registration and amending existing registrations with the agency1,2.
You may also be interested in...
The European Medicines Agency will use feedback from two workshops in September to clarify what data protection issues must be addressed to allow for the secondary use of health and medical data when it comes to developing, monitoring and evaluating medicines.
Although biological medicines carry a very low risk of being contaminated by nitrosamine impurities, the EMA says the possibility cannot be ruled out.
A new EU pilot will help drug regulators and policymakers understand the factors influencing the uneven availability of centrally authorized medicines in the member states.